WALTHAM, Mass.--(BUSINESS WIRE)--Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today that The European Patent Office has granted a patent to Nomir which protects its core Noveon® technology. The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.
